These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6812369)

  • 21. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
    Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
    J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Leukocyte and thrombocyte antibodies in paroxysmal nocturnal hemoglobinuria].
    Kout M; Májský A; Brabec V
    Vnitr Lek; 1973 Jul; 19(7):654-9. PubMed ID: 4726015
    [No Abstract]   [Full Text] [Related]  

  • 23. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.
    Rosse WF; Logue GL; Adams J; Crookston JH
    J Clin Invest; 1974 Jan; 53(1):31-43. PubMed ID: 4855546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitation of serum complement components and plasma C3d in patients with malignant lymphoma: relation to the stage of the tumor and circulating immune complexes.
    Heier HE; Carpentier NA; Lambert PH; Godal T
    Int J Cancer; 1978 Jun; 21(6):695-9. PubMed ID: 669852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunological studies on the presence of thrombocyte antibodies in paroxysmal nocturnal hemoglobinuria].
    Májský A; Brabec V
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(1):93-103. PubMed ID: 4110789
    [No Abstract]   [Full Text] [Related]  

  • 27. Paroxysmal nocturnal hemoglobinuria and complement-mediated erythrocyte damage.
    Parker CJ
    Curr Opin Hematol; 1994 Mar; 1(2):151-6. PubMed ID: 9371274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of the material inhibiting EAC-rosette formation in the sera of patients with nephropathies.
    Smith MD; Verroust PJ; Adam C; Galceran M; Morel-Maroger L
    Clin Exp Immunol; 1977 Dec; 30(3):364-9. PubMed ID: 606450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune complexes and complement components in Bell's palsy.
    Jonsson L; Larsson A; Thomander L
    ORL J Otorhinolaryngol Relat Spec; 1987; 49(6):294-301. PubMed ID: 3501560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating immune complexes in sickle cell anaemia.
    Villaescusa R; Santos MN; Espinosa E; Hernández P
    Haematologia (Budap); 1986; 19(3):185-91. PubMed ID: 3781352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunobiology of complement.
    Burkholder PM; Littleton CE
    Pathobiol Annu; 1971; 1():215-39. PubMed ID: 4129958
    [No Abstract]   [Full Text] [Related]  

  • 32. Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatment.
    Subías Hidalgo M; Martin Merinero H; López A; Anter J; García SP; Ataúlfo Gonzalez-Fernández F; Forés R; Lopez-Trascasa M; Villegas A; Ojeda E; Rodríguez de Córdoba S
    Immunobiology; 2017 Feb; 222(2):363-371. PubMed ID: 27644115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
    J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of cholinergic factors on the state of immunogenesis in animals with paroxysmal nocturnal hemoglobinuria-like hemolytic anemia].
    Martynova VA; Savina LS; Mikhaĭlova EA
    Probl Gematol Pereliv Krovi; 1980 Jun; 25(6):47-50. PubMed ID: 7393880
    [No Abstract]   [Full Text] [Related]  

  • 35. Leukocyte antigen-antibody reaction and lysis of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Sirchia G; Ferrone S; Mercuriali F
    Blood; 1970 Sep; 36(3):334-6. PubMed ID: 5311198
    [No Abstract]   [Full Text] [Related]  

  • 36. Circulating immune complexes in Indian childhood cirrhosis.
    Kalra V; Harkiss GD; Lachmann PJ; Ghai OP
    Clin Exp Immunol; 1982 Oct; 50(1):1-6. PubMed ID: 6924609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
    Davis P; Cumming RH; Verrier-Jones J
    Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
    Logue GL; Rosse WF; Adams JP
    J Clin Invest; 1973 May; 52(5):1129-37. PubMed ID: 4700488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies.
    Aster RH; Enright SE
    J Clin Invest; 1969 Jul; 48(7):1199-210. PubMed ID: 5798625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.